Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://airmax-95.us
Are you over 18 and want to see adult content?
A complete backup of https://planetsushi.fr
Are you over 18 and want to see adult content?
A complete backup of https://hawaii-nation.org
Are you over 18 and want to see adult content?
A complete backup of https://swd-ag.de
Are you over 18 and want to see adult content?
A complete backup of https://zephyronline.com
Are you over 18 and want to see adult content?
A complete backup of https://chardphoto.com
Are you over 18 and want to see adult content?
A complete backup of https://vorgestudio.com
Are you over 18 and want to see adult content?
A complete backup of https://michelegreenmd.com
Are you over 18 and want to see adult content?
A complete backup of https://sfepm.org
Are you over 18 and want to see adult content?
A complete backup of https://bremische-buergerschaft.de
Are you over 18 and want to see adult content?
A complete backup of https://verdar.com
Are you over 18 and want to see adult content?
A complete backup of https://bloknot-volgodonsk.ru
Are you over 18 and want to see adult content?
Favourite Annotations
Značkové hodinky, parfémy, kosmetika a kabelky za skvělé ceny | BRASTY.CZ
Are you over 18 and want to see adult content?
® Blog Católico Gotitas Espirituales ®
Are you over 18 and want to see adult content?
GSB1012 Kesantunan Masyarakat Malaysia
Are you over 18 and want to see adult content?
La Mejor Tienda de Ukuleles de Mexico - Ukuleleria -
Are you over 18 and want to see adult content?
Athens magazine - Κυκλοφορούμε στα καλύτερα
Are you over 18 and want to see adult content?
COIT | Colegio Oficial Ingenieros de Telecomunicación |
Are you over 18 and want to see adult content?
Text
CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
TOTUS MEDICINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
TOTUS MEDICINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA LOCATIONS - LABCENTRAL Locations. LabCentral 700 Main Street, North Cambridge, MA 02139 Get Directions . LabCentral 610 610 Main Street Cambridge, MA 02139 GetDirections. Map
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
ALUMNI COMPANIES
Alumni Companies. LabCentral congratulates our alumni companies! View Company Graduated February 2016. View Company Graduated April 2019. View Company. View Company Graduated January 2017. View Company. View Company Graduated February 2021. View Company Graduated October 2016.KRISTA LICATA
Krista Licata. Krista Licata is the Managing Director of LabCentral Ignite: a platform for collective investment and a ‘spark’ for regional systemic change in STEM Education, talent development/placement and entrepreneurial support in the biotech industry. Prior to this role, Krista spent 7 years providing support to LabCentral’s startups NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
KERNAL BIOLOGICS
Kernal Biologics Inc. is a Cambridge-based startup that is developing messenger RNA therapeutics for Acute Myeloid Leukemia (AML) using deep learning algorithms. AML is a rare blood cancer type that affects 350 thousand people globally, every year. Most patients treated with current standard of care, chemotherapy, develop relapse or recurrence EIKONIZO THERAPEUTICS Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
WHAT IS LABCENTRAL?
What Is LabCentral? LabCentral is a Massachusetts non-profit company, founded in 2013 as a launchpad for high-potential life sciences andbiotech start-ups.
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
VIRALOGIC - LABCENTRAL Viralogic. Coming Soon. Website - Coming Soon. Kevin Friedman CSO. Thomas Galbo Chief Business Officer. Molly Perkins VP of Research. Shannon Contrastano VP, Research. Jonathan Platt Associate Director, LVV CMC. Emily Thompson Dr.GRO BIOSCIENCES
GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at LabCentral in Kendall Square in the heart of the innovation sector in Cambridge, MA. Website. Daniel J. Mandell CEO. Christopher J. GreggCSO.
STRAND THERAPEUTICS
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.LUCY THERAPEUTICS
Lucy Therapeutics. Lucy Therapeutics is a mitochondrial platform company currently focused on small molecule treatments for Rett Syndrome and Parkinson's Disease. LucyTx’s platform and proprietary analytics have led to the discovery and prosecution of targets which can improve the central energetic dysfunctions of these diseases andaddress
LYNDSEY YORK RISSIN
Lyndsey Rissin. Site Head, LabCentral 238 . Lyndsey Rissin is the senior lab manager at LabCentral. She manages the services which support laboratory operations to ensure maximum functionality and efficiency in addition to our team of lab operations associates andleads.
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
WHAT IS LABCENTRAL?
What Is LabCentral? LabCentral is a Massachusetts non-profit company, founded in 2013 as a launchpad for high-potential life sciences andbiotech start-ups.
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
VIRALOGIC - LABCENTRAL Viralogic. Coming Soon. Website - Coming Soon. Kevin Friedman CSO. Thomas Galbo Chief Business Officer. Molly Perkins VP of Research. Shannon Contrastano VP, Research. Jonathan Platt Associate Director, LVV CMC. Emily Thompson Dr.GRO BIOSCIENCES
GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at LabCentral in Kendall Square in the heart of the innovation sector in Cambridge, MA. Website. Daniel J. Mandell CEO. Christopher J. GreggCSO.
ALUMNI COMPANY Q&A: VAXESS TECHNOLOGIES Add to Calendar America/New_York Alumni Company Q&A: Vaxess Technologies Disclaimer: the views, thoughts, and opinions expressed in this blog belong solely to the individual author, and not to LabCentral or the author’s employer, organization or committee. As part of our series to profile resident and alumni companies, we take a look at Vaxess Technologies, an alumni company focused onSTRAND THERAPEUTICS
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.LYNDSEY YORK RISSIN
Lyndsey Rissin. Site Head, LabCentral 238 . Lyndsey Rissin is the senior lab manager at LabCentral. She manages the services which support laboratory operations to ensure maximum functionality and efficiency in addition to our team of lab operations associates andleads.
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
WHAT IS LABCENTRAL?
What Is LabCentral? LabCentral is a Massachusetts non-profit company, founded in 2013 as a launchpad for high-potential life sciences andbiotech start-ups.
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
VIRALOGIC - LABCENTRAL Viralogic. Coming Soon. Website - Coming Soon. Kevin Friedman CSO. Thomas Galbo Chief Business Officer. Molly Perkins VP of Research. Shannon Contrastano VP, Research. Jonathan Platt Associate Director, LVV CMC. Emily Thompson Dr.GRO BIOSCIENCES
GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at LabCentral in Kendall Square in the heart of the innovation sector in Cambridge, MA. Website. Daniel J. Mandell CEO. Christopher J. GreggCSO.
ALUMNI COMPANY Q&A: VAXESS TECHNOLOGIES Add to Calendar America/New_York Alumni Company Q&A: Vaxess Technologies Disclaimer: the views, thoughts, and opinions expressed in this blog belong solely to the individual author, and not to LabCentral or the author’s employer, organization or committee. As part of our series to profile resident and alumni companies, we take a look at Vaxess Technologies, an alumni company focused onSTRAND THERAPEUTICS
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.LYNDSEY YORK RISSIN
Lyndsey Rissin. Site Head, LabCentral 238 . Lyndsey Rissin is the senior lab manager at LabCentral. She manages the services which support laboratory operations to ensure maximum functionality and efficiency in addition to our team of lab operations associates andleads.
PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA LOCATIONS - LABCENTRAL Locations. LabCentral 700 Main Street, North Cambridge, MA 02139 Get Directions . LabCentral 610 610 Main Street Cambridge, MA 02139 GetDirections. Map
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.KRISTA LICATA
Krista Licata. Krista Licata is the Managing Director of LabCentral Ignite: a platform for collective investment and a ‘spark’ for regional systemic change in STEM Education, talent development/placement and entrepreneurial support in the biotech industry. Prior to this role, Krista spent 7 years providing support to LabCentral’s startups MICROQUIN - LABCENTRAL MicroQuin Ltd. is a collaborative US/UK start-up that created two technologies designed to hunt out and treat all breast cancers. The company combined these technologies to create a first-in-class therapeutic (MQ001) that, in preclinical trials, selectively induces 100% cell death within 96 hours across all breast cancers, ignoringhealthy cells.
KERNAL BIOLOGICS
Kernal Biologics Inc. is a Cambridge-based startup that is developing messenger RNA therapeutics for Acute Myeloid Leukemia (AML) using deep learning algorithms. AML is a rare blood cancer type that affects 350 thousand people globally, every year. Most patients treated with current standard of care, chemotherapy, develop relapse or recurrence EIKONIZO THERAPEUTICS Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
PROOF DIAGNOSTICS
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA LOCATIONS - LABCENTRAL Locations. LabCentral 700 Main Street, North Cambridge, MA 02139 Get Directions . LabCentral 610 610 Main Street Cambridge, MA 02139 GetDirections. Map
LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps. SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
THYMMUNE THERAPEUTICS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.KRISTA LICATA
Krista Licata. Krista Licata is the Managing Director of LabCentral Ignite: a platform for collective investment and a ‘spark’ for regional systemic change in STEM Education, talent development/placement and entrepreneurial support in the biotech industry. Prior to this role, Krista spent 7 years providing support to LabCentral’s startups MICROQUIN - LABCENTRAL MicroQuin Ltd. is a collaborative US/UK start-up that created two technologies designed to hunt out and treat all breast cancers. The company combined these technologies to create a first-in-class therapeutic (MQ001) that, in preclinical trials, selectively induces 100% cell death within 96 hours across all breast cancers, ignoringhealthy cells.
KERNAL BIOLOGICS
Kernal Biologics Inc. is a Cambridge-based startup that is developing messenger RNA therapeutics for Acute Myeloid Leukemia (AML) using deep learning algorithms. AML is a rare blood cancer type that affects 350 thousand people globally, every year. Most patients treated with current standard of care, chemotherapy, develop relapse or recurrence EIKONIZO THERAPEUTICS Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNAWHAT IS LABCENTRAL?
What Is LabCentral? LabCentral is a Massachusetts non-profit company, founded in 2013 as a launchpad for high-potential life sciences andbiotech start-ups.
SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps. NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
KRISTA LICATA
Krista Licata. Krista Licata is the Managing Director of LabCentral Ignite: a platform for collective investment and a ‘spark’ for regional systemic change in STEM Education, talent development/placement and entrepreneurial support in the biotech industry. Prior to this role, Krista spent 7 years providing support to LabCentral’s startupsGRO BIOSCIENCES
GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at LabCentral in Kendall Square in the heart of the innovation sector in Cambridge, MA. Website. Daniel J. Mandell CEO. Christopher J. GreggCSO.
LYNDSEY YORK RISSIN
Lyndsey Rissin. Site Head, LabCentral 238 . Lyndsey Rissin is the senior lab manager at LabCentral. She manages the services which support laboratory operations to ensure maximum functionality and efficiency in addition to our team of lab operations associates andleads.
EIKONIZO THERAPEUTICS Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNA PREMIER, BIOTECH-CAPABLE SHARED LAB FACILITY LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.CURRENT RESIDENTS
Current Residents. LabCentral has generated significant interest from entrepreneurs and startups working on groundbreaking science who are eager to join LabCentral, a first-of-its-kind, fully resourced and equipped life-sciences laboratory space. Participants are chosen through a competitive process, where only the highest-potentialapplicants
RECTIFY PHARMACEUTICALS LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.REVITOPE ONCOLOGY
Revitope Oncology is driving immune-control of solid tumors. Immune-based therapies are redefining how cancer is treated, as clinical studies demonstrate unprecedented deep and durable responses in multiple cancer types. In particular, redirecting T cells to tumors is a successful strategy for immunotherapy, but to date is limited byoff-target
LABCENTRAL 610
LabCentral 610 is a 33,000-square-foot facility located across a shared driveway from LabCentral on the third floor of Pfizer’s Kendall Square Worldwide Research and Development building. LabCentral 610 houses up to six early- to mid-stage companies with room to accommodate ~175 scientists and entrepreneurs. Eligible startupsinclude those
GELMEDIX, INC
GelMEDIX, Inc. GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery. Website - Coming Soon. Noel Vera-Gonzalez BiomaterialsScientist. PREV.
CARGENE THERAPEUTICS Cargene is developing oligonucleotide therapeutics across oncology, cardiovascular and fibrotic diseases. With sites in Boston, Singapore and Shanghai, Cargene combines proprietary chemistry with novel biology platforms. Cargene was founded by experienced biotech entrepreneurs XQ Lin, Yann Chong Tan, Professor Torsten Wuestefeld,and is advised
NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
JOHANNES FRUEHAUF
Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. He is the Founder and President ofLabCentral
SUMMATION BIO INC.
Summation Bio Inc. Summation Bio is a gene therapy company developing a novel non-viral gene transfer technology. Summation’s Mini-nucleosome technology addresses the unmet needs in specifically delivering large-sized DNA/RNA to multiple cell types. The Mini-nucleosome technology has the power to enable efficient, regulated and safe DNA/RNAWHAT IS LABCENTRAL?
What Is LabCentral? LabCentral is a Massachusetts non-profit company, founded in 2013 as a launchpad for high-potential life sciences andbiotech start-ups.
SATELLITE BIOSCIENCES, INC. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.LABCENTRAL IGNITE
Employment in biopharma in Massachusetts grew by 45% in 2019. Diversity in our industry lags; the industry is comprised of 3% of people of African descent and 16% of Hispanics/Latinos despite accounting 33% of the overall workforce, respectively. STEM fields have been riddled with persistent representation gaps. NEUTROLIS - LABCENTRAL Neutrolis. Neutrolis is preclinical-stage biotech that develops therapies against the "dark side of DNA.”. DNA is the carrier of our genetic information and stored in our cells. DNA is also a very long molecule, and to fit into a cell; it is packed tightly into chromatinfibers. In
TOTUS MEDECINES INC. Totus Medecines is a chemical biology company that has created a novel drug discovery platform via the seamless integration of structure-based design, combinatorial chemistry, and automated biophysics for the rapid identification of first-in-class oncology therapeutics. Website. Neil Dhawan CEO. Jimmy Blair Head of ChemicalBiology. PREV.
OVIBIO - LABCENTRAL
OVIBIO. OVIBIO is a biotechnology company with a mission to develop next-generation medicines for the prevention and treatment of life-limiting diseases associated with aging. Our approach leverages the remarkable natural systems of the human body to regulate the aging process and fight against disease. Our primary drug developmentprogram
KRISTA LICATA
Krista Licata. Krista Licata is the Managing Director of LabCentral Ignite: a platform for collective investment and a ‘spark’ for regional systemic change in STEM Education, talent development/placement and entrepreneurial support in the biotech industry. Prior to this role, Krista spent 7 years providing support to LabCentral’s startupsGRO BIOSCIENCES
GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, co-founded by Dr. George Church, is located at LabCentral in Kendall Square in the heart of the innovation sector in Cambridge, MA. Website. Daniel J. Mandell CEO. Christopher J. GreggCSO.
LYNDSEY YORK RISSIN
Lyndsey Rissin. Site Head, LabCentral 238 . Lyndsey Rissin is the senior lab manager at LabCentral. She manages the services which support laboratory operations to ensure maximum functionality and efficiency in addition to our team of lab operations associates andleads.
EIKONIZO THERAPEUTICS Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents.Skip to nav
LABCENTRAL
* About
* What Is LabCentral? * Mission and Impact* Team
* Board of Directors* Advisory Board
* Sponsors
* Partners & Supporters * Sponsorship Opportunities* Work With Us
* LabCentral Ignite
* Facilities & Services* Overview
* LabCentral 610
* Learning Lab
* Resident Companies* Current Residents
* Alumni Companies
* News & Events
* News
* Events
* Gallery 1832
* Press Releases
* Photo Galleries
* Email Signup
* Blog
* Contact
* Contact Us
* Locations
* Biotech Careers
* Tour LabCentral
* Apply For Space
* Apply Now
* Process & Criteria* 501(c)(3)
* Terms of Service
* Privacy Policy
* Resident Login
A LAUNCHPAD for high‑potential life‑sciences startups.Learn More
A LAUNCHPAD for high‑potential life‑sciences startups.Learn More
A LAUNCHPAD for high‑potential life‑sciences startups.Learn More
A LAUNCHPAD for high‑potential life‑sciences startups.Learn More
A LAUNCHPAD for high‑potential life‑sciences startups.Learn More
“_The need to access very expensive wet lab space is often what keeps entrepreneurs in the university. This is going to accelerate getting entrepreneurs out of the universities and into the community…_” – Susan Windham-Bannister; Former President, Massachusetts Life Sciences Center "_We hope that LabCentral will be the first of many across the country – a great example…_” - Steve Tregay; CEO, FORMA Therapeutics “_The dream come true for companies that have a proof of concept and don’t have the time to build out a lab, find the space, get more capital…_” – Minka van Beuzekom; Former Cambridge CityCouncillor
“_The last thing startups need is to worry about are their environmental needs… compliance, disposal, hazards or safety… When they come to this place as an innovation center, their only focus should be innovating..._” Greg Rosinski; Senior Manager, Triumvirate “_The ability to go in and access shared laboratory space to test ideas in an early stage of a company is really vital…_” Martin Schmidt; Provost, MIT “_It’s the hottest zip code in the country for biotech and life science. If you have this address – you’re in the game…_” – State Senator, Sal DiDomenico “_In order to have innovation, you need to be able to bump and mingle…in Kendall Square our density of innovators keeps us at the front…_” – Ken Reeves; Cambridge City Councillor, former Mayorof Cambridge
* Everything
* Resident Companies* News & Events
* Social
Resident Company
View Company
News LABCENTRAL VIRTUAL EVENT SERIES: INNOVATION AND BIOTECH IN THE TIME OF COVID-19 Disclaimer: the views, thoughts, and opinions expressed in… View MoreResident Company
View Company
Testimonial We hope that LabCentral will be the first of many across the country - a great example of a… Steve Tregay Learn More Facilities & Services Close proximity to major university research centers, biotech, & pharmaceutical companies Learn MoreResident Company
View Company
Social __ @LABCENTRAL Check out our latest Q&A with Tidal Therapeutics’ Ulrik Nielsen! Learn about his… View TweetResident Company
View Company
Resident Company
View Company
News TIDAL THERAPEUTICS: THE BENEFITS AND LEVERAGE OF THE LABCENTRAL MODEL Disclaimer: the views, thoughts, and opinions expressed inthis… View More
Resident Company
View Company
Facilities & Services Ready-to-go lab: centrifuges, vortex, shakers, glassware, & basic consumables Learn More Learn More About LabCentralLab Central
* About
* Facilities & Services * Resident Companies* News & Events
* Contact
* Apply For Space
700 Main Street, NorthCambridge, MA 02139
MAP
+1617 863 3650
info@labcentral.org
EMAIL SIGN UP
Get the latest updates from the LabCentral blog sent directly to your email by subscribing here.Copyright 2021
LabCentral, Inc.
* 501(c)(3)
* Terms of Service
* Privacy Policy
* Biotech Careers
* Resident Portal
Website by Steady VisionDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0